Abstract

The Ste20-related protein proline/alanine-rich kinase (SPAK) plays important roles in cellular functions such as cell differentiation and regulation of chloride transport, but its roles in pathogenesis of intestinal inflammation remain largely unknown. Here we report significantly increased SPAK expression levels in hyperosmotic environments, such as mucosal biopsy samples from patients with Crohn's disease, as well as colon tissues of C57BL/6 mice and Caco2-BBE cells treated with hyperosmotic medium. NF-κB and Sp1-binding sites in the SPAK TATA-less promoter are essential for SPAK mRNA transcription. Hyperosmolarity increases the ability of NF-κB and Sp1 to bind to their binding sites. Knock-down of either NF-κB or Sp1 by siRNA reduces the hyperosmolarity-induced SPAK expression levels. Furthermore, expression of NF-κB, but not Sp1, was upregulated by hyperosmolarity in vivo and in vitro. Nuclear run-on assays showed that hyperosmolarity increases SPAK expression levels at the transcriptional level, without affecting SPAK mRNA stability. Knockdown of SPAK expression by siRNA or overexpression of SPAK in cells and transgenic mice shows that SPAK is involved in intestinal permeability in vitro and in vivo. Together, our data suggest that SPAK, the transcription of which is regulated by hyperosmolarity, plays an important role in epithelial barrier function.

Highlights

  • Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), are multi-factorial diseases typically associated with relapsing diarrhea, which is caused by increased paracellular permeability of the intestinal epithelial lining and an intestinal hyperosmotic environment [1,2,3,4,5]

  • Real-time PCR and Western-blot analyses showed that colonic mucosa from the same CD patients contained significantly increased Ste20-related protein proline/alanine-rich kinase (SPAK) expression at both the mRNA and protein levels compared with tissue from normal subjects (Fig. 1B and 1C)

  • Expression of SPAK is enhanced in colon tissue from hyperosmolarity treated mice we examined the relative SPAK expression levels in colon samples from healthy mice and mice exposed to hyperosmotic conditions

Read more

Summary

Introduction

Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), are multi-factorial diseases typically associated with relapsing diarrhea, which is caused by increased paracellular permeability of the intestinal epithelial lining and an intestinal hyperosmotic environment [1,2,3,4,5]. Intestinal epithelial cells (IECs) are exposed to the second most extreme osmotic environment after kidney. In many forms of IBD, including CD, neonatal necrotizing enterocolitis and UC, this extreme hyperosmolarity contributes to the exacerbation of intestinal inflammation via upregulation of inflammatory molecules such as matrix metalloproteinase (MMP)-9 [6], epithelial cytokine response-interleukin (IL)-8 [7,8,9,10], IL-1 [11,12,13], and tumor necrosis factor (TNF)-a [13], downregulation of vascular cell adhesion molecule (VCAM)-1 [14], or methylation of protein phosphatase 2A [15]. Hyperosmolarity has been proposed to play a role in intestinal inflammation in several inflammatory bowel diseases, including CD and UC, as well as newborn and neonatal necrotizing enterocolitis [1,2,3,4,5]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call